剖宫产瘢痕妊娠延续至中晚孕期的严重不良结局:系统综述与荟萃分析
该系统综述与荟萃分析纳入61项研究,其中20项研究(432例)进入定量分析,评估单胎剖宫产瘢痕妊娠(CSP)延续至≥14周妊娠后胎盘植入谱系疾病(PAS)及子宫切除的发生率与风险。PAS和子宫切除的合并发生率分别为0.90(95%CI 0.81-0.96)和0.39(95%CI 0.22-0.57)。III型和外生型CSP风险显著更高,残余肌层厚度(RMT)≤3mm与PAS风险增加相关。
要点
- III型及外生型CSP延续至中晚孕期时PAS和子宫切除风险显著升高
- RMT≤3mm与总体及侵入性PAS风险增加显著相关,并可预测子宫切除
- CSP延续至中晚孕期足月(≥37周)分娩的合并发生率仅为0.19(95%CI 0.10-0.30)
核心结论
- III型和外生型CSP延续至中晚孕期时PAS和子宫切除风险高,足月分娩可能性低。
- I型、II型和内生型CSP不良结局风险相对较低。
- CSP分型和RMT是风险分层和个体化咨询的关键决定因素。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、EMBASE、Cochrane Library、ClinicalTrials.gov、CNKI和Yiigle数据库至2025年2月12日。
- 纳入报告单胎CSP延续至≥14周妊娠的PAS和/或子宫切除发生率的研究。
- 系统综述纳入61项研究,其中20项研究(432例)进入荟萃分析。
- 采用随机效应模型合并发生率和比值比(95%CI),并按CSP亚型和RMT进行亚组分析。
主要发现
- PAS合并发生率为0.90(95%CI 0.81-0.96),子宫切除合并发生率为0.39(95%CI 0.22-0.57)。
- III型和外生型CSP分别较I/II型和内生型相比,侵入性PAS、子宫切除和早产的比值比显著更高。
- RMT降低与总体PAS和侵入性PAS的比值比增加显著相关,ROC曲线分析提示可预测子宫切除。
- 达到≥28周妊娠的合并发生率为0.85(95%CI 0.73-0.94),达到足月(≥37周)的合并发生率为0.19(95%CI 0.10-0.30)。
- 报告子宫破裂的研究中,该结局的合并发生率为0.05(95%CI 0.02-0.10)。
关键数值与推荐
- PAS合并发生率0.90(95%CI 0.81-0.96)。
- 子宫切除合并发生率0.39(95%CI 0.22-0.57)。
- ≥28周妊娠合并发生率0.85(95%CI 0.73-0.94),≥37周为0.19(95%CI 0.10-0.30)。
- 子宫破裂合并发生率0.05(95%CI 0.02-0.10)。
- III型和外生型CSP与侵入性PAS、子宫切除和早产风险增加相关;RMT降低与总体及侵入性PAS风险增加相关。
临床怎么用
- 对延续至中晚孕期的CSP,应根据CSP分型(III型/外生型)和RMT进行风险分层。
- III型和外生型CSP应加强产前评估和个体化咨询,重点关注PAS和子宫切除风险。
- RMT≤3mm可作为预测PAS和子宫切除风险的参考指标。
局限性
- 研究间异质性高,采用随机效应模型进行合并。
- 仅20项研究(432例)进入荟萃分析,样本量有限。
- 原始研究间CSP分型和RMT定义可能存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review systematically and assess quantitatively the incidence and risk of placenta accreta spectrum (PAS) disorders and hysterectomy in Cesarean scar pregnancy (CSP) continuing into mid-to-late gestation. METHODS: A comprehensive literature search was performed in PubMed, EMBASE, Cochrane Library, ClinicalTrials.gov, China National Knowledge Infrastructure (CNKI) and Yiigle databases from inception to 12 February 2025. Studies reporting the rates of PAS and/or hysterectomy in women with a singleton CSP that continued ≥ 14 weeks' gestation were eligible for inclusion. Data extracted included information on medical history, CSP classification and clinical manifestation, gestational age at delivery and pregnancy outcome. Data were synthesized as pooled incidences and odds ratios with 95% CIs, and random-effects models were used owing to high heterogeneity. Subgroup analyses were performed according to CSP subtype (Type I vs Type II vs Type III; and endogenous vs exogenous) and residual myometrial thickness (RMT) (≤ 3 mm vs > 3 mm). RESULTS: Among 61 studies included in the systematic review, 20 studies (432 cases) were eligible for inclusion in the meta-analysis. Qualitative synthesis captured severe clinical phenotypes, including spontaneous uterine rupture and massive hemorrhage during Cesarean section. The pooled incidences of PAS and hysterectomy were 0.90 (95% CI, 0.81-0.96) and 0.39 (95% CI, 0.22-0.57), respectively. Marked heterogeneity was observed across CSP subtypes: Type-III and exogenous CSPs were associated with significantly higher odds of invasive PAS, hysterectomy and preterm delivery compared with Types-I/II and endogenous subtypes, respectively. Reduced RMT was associated significantly with increased odds of overall PAS and invasive PAS, and was predictive of hysterectomy on receiver-operating-characteristics-curve analysis. The pooled incidence of reaching ≥ 28 weeks' gestation was 0.85 (95% CI, 0.73-0.94), whereas the pooled incidence of reaching term (≥ 37 weeks) was 0.19 (95% CI, 0.10-0.30). Among studies that reported uterine rupture, the pooled incidence of this outcome was 0.05 (95% CI, 0.02-0.10). CONCLUSIONS: Type-III and exogenous CSPs that progress into mid-to-late gestation present substantial risks for PAS and hysterectomy, with a low likelihood of term delivery. Type-I, Type-II and endogenous CSPs are associated with a comparatively lower risk of adverse outcome. CSP subtype and RMT are key determinants for risk stratification and individualized counseling. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Zeng S, Tian Y, Qu J, et al. Adverse outcome in Cesarean scar pregnancy continuing into mid-to-late gestation: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2026. PMID: 42487537. doi:10.1002/uog.70293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。